title: American Society of Clinical Oncology--40th Annual Meeting. EGFR/VEGF. 5-8 June 2004, New Orleans, LA, USA.
authors.affiliation: Thomson Scientific, Middlesex House, 34-42 Cleveland Street, London, W1T 4JE, UK. rebecca.erlich@thomson.com
authors.forename: Rebecca
authors.initials: R
authors.lastname: Erlich
authors.forename: Ruth
authors.initials: R
authors.lastname: Harrison
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
chemical_list: D000970:Antineoplastic Agents; D042461:Vascular Endothelial Growth Factor A; D066246:ErbB Receptors